Sells prescription drugs and topical antimicrobials through drug wholesalers, cosmetic ingredients through distributors, and medical lubricants to medical-product makers.
10-K for FY2025, filed Mar 27, 2026Pharmaceutical Products: Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to…View ↗
We sell our pharmaceutical products primarily to three national full-line drug wholesalers, which in turn supply those products to…View ↗
We generally ship our cosmetic ingredients to our distributors Ex Works (“EXW”) from our facility in Hauppauge, New York. The distributors…View ↗
Our medical lubricants are sold directly to manufacturers and marketers of finished medical products or to the contract manufacturers…View ↗
Customers buy products outright; the company ships before payment, which typically follows under customer-specific credit terms.
10-K for FY2025, filed Mar 27, 2026Our cosmetic ingredients are currently marketed globally by five distributors, of which Ashland Specialty Ingredients (“ASI”), a business…View ↗
As long as a valid purchase order has been received and future collection of the sale amount is reasonably assured, the Company recognizes…View ↗
The timing between recognition of revenue for product sales and the receipt of payment is not significant. The Company’s standard credit…View ↗
10-K for FY2025, filed Mar 27, 2026
FY2025 revenue by product or service ↗$10.5M
10-K for FY2025, filed Mar 27, 2026
$10.5M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Cosmetic Ingredients
Sold outright
10-K for FY2025, filed Mar 27, 2026 |
29%
FY2022: 41%
|
Cosmetic Ingredients, FY2025
$3M Sources
|
Sold outright |
|
Pharmaceuticals
Sold outright
10-K for FY2025, filed Mar 27, 2026 |
51%
FY2022: 39%
|
Pharmaceuticals, FY2025
$5.4M Sources
|
Sold outright |
|
Medical Lubricants
Sold outright
10-K for FY2025, filed Mar 27, 2026 |
20%
FY2022: 19%
|
Medical Lubricants, FY2025
$2.1M Sources
|
Sold outright |
Cosmetic-ingredient distributors resell to personal-care and cosmetic manufacturers; drug wholesalers supply pharmacies, physicians and hospitals. Medical-product marketers and their contract manufacturers buy lubricants directly.
10-K for FY2025, filed Mar 27, 2026We generally ship our cosmetic ingredients to our distributors Ex Works (“EXW”) from our facility in Hauppauge, New York. The distributors…View ↗
We sell our pharmaceutical products primarily to three national full-line drug wholesalers, which in turn supply those products to…View ↗
Our medical lubricants are sold directly to manufacturers and marketers of finished medical products or to the contract manufacturers…View ↗
Yes. It kept 20 cents of every revenue dollar as net income in FY2025 and turned 18 cents into free cash flow.
10-K for FY2025, filed Mar 27, 2026
$2.2MView ↗
10-K for FY2025, filed Mar 27, 2026
$2.1MView ↗
10-K for FY2025, filed Mar 27, 2026
$1.9MView ↗
10-Q for Q2 FY2026, filed Aug 11, 2026
$728.6KView ↗
10-Q for Q2 FY2026, filed Aug 11, 2026
Open tableView ↗
Shrinking. Revenue fell 24% in 4 years, from $13.9M in FY2021 to $10.5M in FY2025, about 7% a year.
Portfolio mix
The older report included specialty industrial products and said their sale would be discontinued; the latest report includes sexual wellness ingredients among its product categories.
10-K for FY2022, filed Mar 23, 2023 10-K for FY2025, filed Mar 27, 2026Our products are sold into stable and growing markets such as personal care, medical lubricants and pharmaceutical products. Our current…View ↗
Our products are sold into stable and growing markets such as personal care, medical devices and healthcare. Our current product offerings…View ↗
Loading...